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Abstract
Purpose—Ionizing radiation is a well established carcinogen in rodent models and a risk factor
associated with human cancer. We developed a mouse model that captures radiation effects on
host biology by transplanting unirradiated Trp53 null mammary tissue to sham or irradiated hosts.
Gene expression profiles of tumors that arose in irradiated mice are distinct from those that arose
in naïve hosts. We asked whether expression metaprofiles could discern radiation-preceded human
cancer or be informative in sporadic breast cancers.
Experimental Design—Affymetrix microarray gene expression data from 56 Trp53 null
mammary tumors were used to define gene profiles and a centroid that discriminate tumors arising
in irradiated hosts. These were applied to publicly available human cancer data sets.
Results—Host irradiation induces a metaprofile consisting of gene modules representing stem
cells, cell motility, macrophages and autophagy. Human orthologs of the host irradiation
metaprofile discriminated between radiation-preceded and sporadic human thyroid cancers. An
irradiated host centroid was strongly associated with estrogen receptor negative breast cancer.
When applied to sporadic human breast cancers, the irradiated host metaprofile strongly associated
with basal-like and claudin-low breast cancer intrinsic subtypes. Comparing host irradiation in the
context of TGFβ levels showed that inflammation was robustly associated with claudin-low
tumors.
Conclusions—Detection of radiation-preceded human cancer by the irradiated host metaprofile
raises possibilities of assessing human cancer etiology. Moreover, the association of the irradiated
host metaprofiles with estrogen receptor negative status and claudin-low subtype suggests that
host processes similar to those induced by radiation underlie sporadic cancers.
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Ionizing radiation is one of very few environmental exposures unequivocally associated with
increased cancer risk in humans (1), particularly in thyroid and breast cancer following
exposure at a young age (2–3). Breast cancer increases in women who survived the atomic
bombs (4), received diagnostic radiation for tuberculosis (5), or were treated with radiation
for benign breast disease (6). Twenty percent of women treated with radiation for Hodgkin’s
lymphoma develop breast cancer before the age of 40 (7). Breast cancer is a complex
disease that consists of at least six intrinsic subtypes identified by gene expression profiling
(8–10) that can be prognostic (11–12). Recent studies suggest that prior exposure to
radiation promotes aggressive, estrogen receptor (ER) negative tumors(13–15).
Radiation is a complete carcinogen able to both initiate and promote cancer. Initiation,
thought to be due to oncogenic mutations from mis-repaired double DNA breaks, is widely
believed to be the critical event for radiation carcinogenesis (16), however host systemic and
stromal responses can also contribute to radiation’s carcinogenic potential (17–20). To test
whether host biology contribute to radiation carcinogenesis, we established a radiation
chimera model that separates radiation effects on the host from those on the target
epithelium (21). In this model, the mammary gland is cleared of endogenous epithelium of
host mice, which are subsequently irradiated and then transplanted orthotopically with non-
malignant Trp53 null mammary tissue (22), which has many similarities to human breast
cancer, including progression from pre-neoplastic lesions to ductal carcinoma in situ to
tumors with diverse histopathologies (23–24). Even though host irradiation occurred many
months before tumor development and the mammary epithelium was never irradiated, the
course of Trp53 null carcinogenesis is significantly altered by host irradiation as evidenced
by decreased tumor latency and more rapid tumor growth rate. Unexpectedly, host
irradiation also increased the proportion of ER negative tumors. Expression profiles of
Trp53 null tumors arising in an irradiated host compared to those arising in non-irradiated
hosts were also distinct, suggesting that the biology elicited by radiation has long lasting
effects on tumor development (22). Network analysis of the irradiated host signature
implicated two critical factors, TGFβ and mammary stem cells that were validated with
additional experiments, demonstrated at least two distinct mechanisms by which the
irradiated microenvironment promotes breast cancer (22).
Detailed understanding of the basis for cancer characteristics and clinical behaviors in
irradiated populations could improve risk predictions, and may uncover means to reduce
risk. We speculated that expression metaprofiles might discern radiation-preceded human
cancer and be informative in sporadic breast cancers. We used bioinformatics to evaluate the
value of murine irradiated host signatures for classifying radiation-preceded human cancers
and its associations with sporadic breast cancer.
Methods
Data from Affymetrix mouse Genechip MG-430 2.0 arrays from our prior study (22),
GSE18216 NCBI Gene Expression Omnibus database accession number, were used, in
addition to 8 addition samples (merged under GSE42742). Background was normalized
using robust multichip average algorithm (25), R software v2.10.1, with widgets specific to
the Affymetrix platform. Unsupervised hierarchical clustering using Gene Cluster v3.0
software was visualized using Java TreeView v1.1.4r3 software. Data was mean centered;
gene clustering was done by an uncentered-correlation and array clustering was done by
Spearman Rank correlation; under complete linkage. Pathways were identified with
Ingenuity Pathway Analysis, or ConceptGen (http://conceptgen.ncibi.org/core/conceptGen/
index.jsp).
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Irradiated Murine Host Signature
Significance of analysis of microarray (SAM) used a two-class analysis with 100
permutations per comparison of the reference class to the target class, followed by a fold-
change cut-off of 1.5 (26). To increase stringency, a secondary, or “tandem,” bootstrapping
was done by running the above SAM analysis iteratively, removing one sample from the
reference class each time, including an iteration that removed no samples, to generate a list
of genes regulated ≥1.5-fold present in 80% of the secondary SAM analyses.
Microarray data from 1608 human breast tumors from Ringner et al. and 337 untreated
human breast cancer from Prat et al. (27–28) classified into molecular subtypes were used
for cross-species comparison (28). Human orthologs of murine genes present on the human
array platforms were used to cluster human microarray data using Gene Cluster as above.
Genes in human microarray data were filtered by a criteria of Log 2-value >5 in 80% of the
samples, before isolating the genes for clustering. In some analyses, the validity of
clustering was tested against the performance of 10,000 randomly selected gene sets of the
same size. Spearman’s correlation and complete linkage was used to assess the distribution
of irradiated and sham samples in the first divisions of the clustering dendrogram, excluding
dendrograms with less than five samples in these branches.
Irradiated Host Centroid
To construct the irradiated host centroid, gene expression data (n=32) was filtered to include
only genes with an expression above background in more than 75% of the samples. A t-test
based p-value of the median centered probes present in the irradiated host signature was
calculated for each gene based on separation of samples on irradiation status. Gene
expression centroids were calculated for probes with a <0.01 p-value, leaving 133 of the
original 323 probes. For classification of human tumors, mouse probes were translated to
human genes using cross-referenced Entrez Gene IDs, leaving 72 genes in the centroid.
Breast cancers were assayed for nearest centroid classification using Spearman correlation
for the irradiated(IR-host)and the sham (S-host)gene expression centroids.
Results
Host irradiation induces a distinct metaprofile in Trp53 null murine mammary tumors
Expression profiles from 56 tumors arising from Trp53 null fragments transplanted to
cleared mammary glands of control or previously irradiated wildtype or Tgfb1 heterozygote
3 month old mice were previously reported (22). Subsequently, Herschkowitz et al. showed
that the transcriptional profiles of Trp53 null tumors can be classified into molecular
subtypes, including two basal-like classes, luminal, claudin-low similar to human breast
cancer, and a subtype unique to this model (29). To determine whether the host irradiation
affected the spectrum of intrinsic molecular subtypes, a intrinsic gene list, previously
defined for mouse tumors (30), was used for hierarchical clustering analysis of expression
profiles from these 56 tumors with 187 murine mammary tumors, including 50 other Trp53
null tumors, and 10 mouse mammary glands. SigClust (31) was used to assess the
significance of tumor clustering and objectively determine significant groups/subtypes
(Figure 1, Table S1). SigClust assigned these newly analyzed 56 Trp53 null tumors to basal-
like(5/56), claudin-low (14/56), luminal (19/56) and p53 null (6/56) intrinsic subtypes. Two
clusters of tumors, mostly from irradiated hosts (11/12), were unclassified by this method.
The distribution of tumor subtypes as a function of either host irradiation and/or host
genotype was not significantly different as determined by Chi-square (data not shown).
Yet host irradiation confers a distinct expression signature on tumor transcriptomes (22).
Since tumors arising in irradiated hosts were not enriched in a particular tumor subtype, we
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concluded that the gene lists that define tumors arising in irradiated hosts are metaprofiles
that overlay intrinsic subtype. To further explore this biology, we generated an irradiated
host profile list of 323 genes (Table S2) significantly regulated by at least 1.5-fold in at least
80% of the secondary SAM bootstraps. As expected, tumors were clustered according to
prior host irradiation (Figure 2A). Ingenuity Pathway Analysis (IPA) implicated
inflammation as a key process imposed by the irradiated host environment. The top IPA
interaction network included inflammatory response, cell-to-cell signaling and interaction,
and organismal survival (Figure 2B; IPA Score 54). Specific inflammatory programs
included proliferation of T-lymphocytes (p=8.5E-5, 21 genes), chemotaxis (p=3.1E-4, 20
genes), and cell movement of phagocytes (p=0.002, 16 genes). Four gene networks
representing two cell types, stem cells and macrophages, and two processes, motility and
autophagy were evident(Figure 2C).
The irradiated host signature segregates radiation preceded human cancer
To test whether this host biology is applicable to other experimental models, we applied this
gene list to published data from sporadic or radiation-preceded rat sarcomas (32) and murine
Ptch1 mutant medulloblastoma (33). Most radiation-induced sarcoma and medulloblastoma
were clustered by this profile (Figure S1A&B).
Encouraged by this evidence that the biology captured by the radiation chimera is useful
across tumor types and species, we searched for expression profile microarray of human
sporadic cancers compared to those preceded by radiation. Very few radiation-induced
tumor microarray data sets are amenable to analysis due to sample size or platform
differences (15, 32, 34–36). We applied the irradiated host signature to radiation-preceded
papillary thyroid carcinomas (36) and radiotherapy associated sarcomas (32) (Figure 2D,E).
Clustering using this subset of human gene orthologs present from the murine signature
resulted in segregation of sporadic from radiation-preceded cancers. Permutation analysis
showed that segregation by the genes from the irradiated host was significantly better than
randomly selected genes in radiation-preceded thyroid cancers (p<0.02). This analysis
suggests that host response to radiation, as defined by the radiation chimera model, also
significantly affects the transcriptome of cancers arising in irradiated humans.
Association of irradiated host metaprofile and human breast cancer intrinsic subtypes
We devised a metric by which to classify breast cancers as similar to tumors from irradiated
hosts by making a centroid classifier from the 323 irradiated host signature, defined herein.
One centroid represents tumors from non-irradiated wildtype hosts, and second one
represents tumors from irradiated WT hosts, both based on 72 of the most differentially
expressed genes of the 323 gene list. As expected, the 72-gene centroid (Table S3)
discriminates Trp53 null tumors from sham-irradiated hosts and irradiated hosts (Figure
3A). ER status, based on immunostaining, was distributed independently (Figure 3B), even
though more ER-negative breast tumors arose in irradiated hosts (22), which is consistent
our previous report of a distinct signature that discriminated ER-negative tumors arising in
an irradiated host (22). We used the centroid to assign human breast cancers compiled by
Ringnér et al. (28) according to similarity to sham or irradiated host centroid. Most ER-
positive breast cancers associated with the sham host signature while ER-negative breast
cancers were strongly associated with irradiated host signature (Figure 3C). This suggests
that the transcriptome in sporadic ER-negative, basal-like human breast cancer is influenced
by tissue processes similar to those that promote ER-negative tumorigenesis in the radiation-
chimera murine model. Several intrinsic subtypes are represented in ER-negative breast
cancer, as evident in the data set from Prat et al. (10). Principle component analysis of the 72
genes in the centroid within the Prat UNC-337 data set demonstrated that claudin-low
tumors were most strongly associated with the irradiated host centroid (Figure 3D).
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Metaprofiles are gene expression modules consisting of co-expressed genes that represent
key biological processes that have prognostic or treatment predictive power for cancer (37–
38). Equipped with a gene list that had many orthologs present on human microarray
platforms, we next determined how the biology represented in the irradiated host metaprofile
applied to two data sets of sporadic human breast cancers. The first consists of 1608 breast
cancers (28). Human orthologs of 182 of the 323 irradiated host gene list clustered tumors
into two major groups, each of which had two subgroups (Figure 4A). Each of the four
major subgroups was enriched with a particular intrinsic subtype, which were associated
with different up-regulated genes (Table S4).
Subgroup 1A consisted of predominantly luminal A and B breast cancers that have an
intermediate prognosis and disease free survival compared to the other groups (Figure 4
B,C). Group 1B contained a block of basal-like breast cancers and ERBB2 tumors and fared
poorly, as is consistent with prior reports for these intrinsic subtypes (10, 39). Group 2C
contained many normal-like tumors and luminal subtypes, and had a similar overall survival
and relapse free survival as Group 1A. Notably Group 2D consisted of a mix of tumors that
exhibited longer overall and disease free survival.
It is thought that the poor prognosis of basal-like and luminal-B subtypes is due to increased
proliferation, as indicated by expression of many proliferation-related genes. To test the
extent to which proliferation was driving the ability of irradiated host gene list to cluster the
compiled breast cancer profiles, we removed 64 genes that were identified as being involved
in “proliferation of eukaryotic cells” as annotated in IPA (Table S5). The remaining 118
genes of the irradiated host gene list still segregated breast cancers into four main subgroups
enriched for molecular subtypes (Figure S2A). Without proliferation genes, the luminal-B
cancer no longer shared the main bifurcation with the basal-like subcluster. Evenso, 1B was
both strongly enriched in basal-like breast cancer and had a much worse relapse-free
survival compared to the other subgroups, suggesting that the biology elicited by irradiated
host is an important factor in prognosis of these tumors.
We next tested the utility of the irradiated host gene list in the data set from Prat et al. (10),
which classified 337 human breast cancers (UNC337) into 6 intrinsic subtypes with the
addition of the 6th type characterized as claudin-low. Using 203 human orthologs of the
irradiated host genes clustered basal-like tumors, normal-like tumors and two distinct groups
of claudin-low tumors (Figure 5A). Notably, claudin-low and basal-like tumors were on
different arms.
Three gene clusters appear to define the clustering of the subtypes (Table S6). Cluster a
contains 16 genes involved in tumorigenesis (p=8.9E-4); cluster b contains 19 genes
involved in immune response (p=5.3E-8); and cluster c contains 29 genes involved in
genetic disorders (p=2.3E-3). Expression of each of these gene clusters was significantly
different among the six subtypes (Figure 5B–D). Principle component analysis of these data
indicates that basal-like breast cancers are enriched for genes in cluster a, claudin-low are
enriched in cluster b, and both tumors are depleted of genes in cluster c.
Claudin-low tumors exhibit epithelial-to-mesenchymal transition (EMT) features and are
enriched in genes associated with stem cell biology (10). TGFβ is a key driver of EMT and
mediates various aspects of stem cell biology, and is highly induced by ionizing radiation
(reviewed in (40)). The radiation chimera experiment conducted in Tgfb1 heterozygote hosts
showed that the effect of host irradiation on tumor latency and growth rates was TGFβ
dependent, while the effect on ER-status was not (22). We speculated that the profiles of
tumors arising in irradiated Tgfb1 heterozygote hosts compared to those arising in control
mice would be informative. Significance of analysis of microarray (SAM) was done using a
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two-class analysis with 100 permutations per comparison of the reference class to the target
class, followed by a fold-change cut-off of 1.5, followed by a secondary “tandem,”
bootstrapping(26). Interestingly, tumors arising in unirradiated hosts of either genotype were
indistinguishable using this method. A list of 199 genes that were present in 100% of the
secondary SAM analyses were able to segregate tumors of irradiated Tgfb1 heterozygote
hosts from those of non-irradiated heterozygote hosts under unsupervised hierarchical
clustering, independent of ER status or histopathology subtype (Figure 6A). It did not do so
when applied to tumors from wild type hosts (Figure 6B). Thus, host-irradiation, in
conjunction with host TGFβ levels, elicits distinct transcriptional biologies of Trp53 null
tumors.
IPA revealed enrichment for cancer related genes, along with inflammatory processes such
as recruitment and activation of lymphocytes and phagocytes (all p<0.005). Gene
enrichment analysis using the ConceptGen database identified extracellular matrix programs
and activation of monocytes, macrophages, and dendritic cells (all p<0.005) (data not
shown). Eight genes, seven of which are “stem-related”, are present in gene lists from both
irradiated wildtype and Tgfb1 heterozygote mice. However, five of seven genes are
oppositely regulated between the two profiles. Tp63, Igfbp2 and Id4 are up-regulated in the
irradiated host signature from wildtype irradiated mice, but down-regulated in that from
Tgfb1 heterozygote mice. This inverse pattern indicates that TGFβ is a critical component of
the radiation response. For example, Cd133, a marker of progenitor cells and cancer
initiating cells in several cancer types including breast cancer (41–43), is present only in
profile from Tgfb1 heterozygote mice.
We then applied this gene list to the UNC337 breast cancers. This list clustered breast
cancer into two arms that represented roughly basal-like, ER-negative cancers and luminal,
ER-positive cancers (Figure 6C). In contrast to clustering using the wildtype irradiated host
signature, claudin-low and basal-like were no longer in distinct arms, indicating that the
biology resulting from TGFβ provides an important distinction between ER-negative basal-
like and claudin-low tumors (Table S6). Together these analyses suggest that processes
promoting cancer in the irradiated mouse are strongly associated with spontaneous basal-like
and claudin-low human breast cancer, the latter of which is particularly influenced by TGFβ
associated inflammatory processes.
Conclusions
Here we show that a gene signature derived from a murine mammary radiation chimera
model is informative in both radiation-preceded and sporadic human cancer, underscoring
the contribution of host biology during cancer evolution. The Trp53 null tumor subtype
distribution was not particularly affected by host irradiation; rather, a distinct tumor
microenvironmental transcriptome signature could be discerned, suggesting that tumors
were “imprinted” by prior host radiation exposure. Together our analyses support the idea
that the radiation response of the microenvironment is a significant component of the
carcinogenic process. Moreover, subtype segregation using this signature suggests that
similar processes may underlie the development of specific subtypes of apparently sporadic
breast cancers.
The 323 irradiated host signature identified herein was enriched for genes indicative of
inflammation, including a macrophage module, suggesting that either the recruitment or
activation of inflammatory cells may underlie the effect of radiation on cancer. The human
gene orthologs of a centroid classified breast cancers into distributions that suggest that a
subgroup of ER-negative, basal-like intrinsic subtypes were like Trp53 null tumors that
arose in the irradiated hosts. The relevance of the Trp53 null mammary model is supported
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by recent report of the Cancer Genome Atlas network on the molecular portraits of human
breast cancer (44). The study group found that 80% of basal-like breast cancers harbored
mutations in TP53, most of which were nonsense and frame shift mutations. The ER-
negative, TP53 mutant, basal-like subtype was distinct from the other subtypes across all
mRNA, miRNA, sequencing, and DNA copy number array platforms, suggesting that
perhaps similar mechanisms may be detected in radiation-preceded cancer. The human
orthologs of the irradiated murine host signature clustered two breast cancers datasets into
groups with distinct outcomes and discriminated between closely related basal-like and
claudin-low breast cancers. Of particular interest is that TGFβ mediated inflammatory
processes strongly define the claudin-low breast cancers (45).
The signature derived from the radiation chimera model also provided important insights
into features of sporadic human breast cancer. Several recent studies have turned attention to
the stroma to derive prognostic value by using expression profiling of stromal and
extratumoral tissues (46). Using microdissected stroma from breast cancer, Finak et al.
showed that a stroma-derived prognostic predictor stratifies disease outcome based on a
signature of immune mediators, hypoxia and angiogenesis (47). Analysis of the expression
profiles from invasive breast cancer and ductal carcinoma in situ provides evidence that
stromal biology is a key determinant of progression (48). Consistent with this, the presence
of distinct subtypes of microenvironment, an active versus inactive cancer-adjacent
microenvironment, influences the aggressiveness and outcome of ER positive human breast
cancers (46). Our data suggests that host biology induced in the radiation chimera model has
strong parallels to the biology that underlies aggressive, ER-negative sporadic breast
cancers.
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Radiation has long been established as a risk factor for breast cancer with recent evidence
suggesting that it promotes estrogen receptor negative cancers in mice and humans.
Human breast cancer comprises at least six transcriptional subtypes, each with distinct
molecular programs. We report that the human orthologs of a mouse mammary tumor
transcriptional program elicited by prior host irradiation can be used to segregate
radiation preceded cancers. Moreover, this program is associated with ER-negative
human breast cancer subtypes, suggesting that sporadic cancer is promoted by similar
biological processes.
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Figure 1. Trp53 null murine mammary tumors classified into intrinsic molecular subtypes
Gene expression profiling of 56 Trp53 null murine mammary tumors arising in the radiation
chimera model consisting of either wild type or Tgfb1 heterozygote hosts were classified by
the SigClust method into intrinsic mouse subtypes (basal-like, red; claudin-low, black;
Trp53 null, light blue; luminal, dark blue; unclassified type 1, light gray; unclassified type 2,
dark gray). They were also clustered along with 187 other tumors from various mouse
mammary tumor models, including 10 normal mammary glands (box). (Sham-irradiated
host, red; irradiated-host, purple; wild type, brown; Tgfb1 +/−, yellow.)
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Figure 2. Tumors arising in irradiated hosts exhibit distinct gene expression program
(A) SAM identified 323 genes regulated by at least 1.5-fold in tumors arising in wild type
irradiated hosts, which cluster host-irradiation status apart from sham-host-irradiation. (B)
IPA interactome of this gene list implicated inflammation, proliferation and development as
major biological activities. (C) The four identified gene networks represent macrophages,
stem cells, autophagy, and cell motility. (D) Radiation-preceded human thyroid cancers
were clustered by 139 of the murine genes present in that data set. Sporadic thyroid cancers
were segregated from radiation-preceded cancers in children from Chernobyl. Chi-square
test of association between irradiation status and the main dendrogram bifurcation, p=0.02.
(E) Radiotherapy associated sarcomas were clustered by 92 human orthologs present from
the murine data set. Red: Sporadic; Purple: radiation-preceded
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Figure 3. The irradiated host centroid associates with distinct human breast cancer intrinsic
subtypes
Two centroids, one representing non-irradiated hosts (S-host) and the other irradiated hosts
(IR-host), were derived based on 72 genes that were most differentially expressed within the
323 host irradiated profile. (A) The correlation of murine Trp53 null tumors with the IR-host
and S-host centroids demonstrates robust discrimination, as expected. (B) The distribution of
murine tumors as a function of ER status is homogenous (ER-positive, green; ER-negative,
red). (C) Contour plot of ER-positive and negative status of 1608 human breast cancers from
by Ringnér et al. (28), after calculating their correlations to the two centroids. The
distributions of ER-positive breast cancer (green) and ER-negative breast cancer (red) are
significantly different (KS test p-value = 6.5E-36). (D) Analysis of variance plots of the
expression of the 72 genes across each breast cancer subtype in the UNC337 data set
indicate distinct behaviors of the claudin-low breast cancers compared to other subtypes.
Nguyen et al. Page 14













Figure 4. The irradiated host gene profile stratifies human breast cancers into prognostic groups
(A) Unsupervised clustering of 1,608 human breast cancers compiled from 10 independent
studies were clustered using 182 orthologs of the murine genes. Tumors were segregated
into four subgroups, some of which contained a predominant molecular subtype (luminal-A,
dark blue; luminal-B, light blue; ERBB2/HER2, purple; basal-like, red; normal-like, green;
and unclassified, gray). Black bars represent the three gene clusters (a, b, c) that represent
genes induced within the four subgroups. (B, C) The four major subgroups exhibited
significantly different overall survival (B) and relapse-free survival (C); (Group 1A, orange;
Group 1B, green; Group 2C, blue; Group 2D, purple).
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Figure 5. The irradiated host gene profile stratifies claudin-low breast cancers apart from other
subtypes
(A) 337 human breast cancers from Prat et al. (2010) were clustered by 203 of the murine
genes present and resulted in four subgroups that were enriched for particular subtypes of
breast cancer (luminal-A, dark blue; luminal-B, light blue; HER2, purple; basal-like, red;
claudin-low, black; normal-like, green; unclassified, gray). Gene clusters, a, b, and c, are
indicated by black bars. (B-D) Analysis of variance of the median expression level for each
gene module highlighted in (A) across each of the six intrinsic subtypes. (B) Basal-like
tumors are strongly associated with gene cluster a (ANOVA p=8.7E-72), representing
tumorigenesis-related genes. (C) Claudin-low tumors are strongly associated with gene
cluster b (ANOVA p=3.9E-20) representing immune response genes. (D) Both basal-like
and claudin-low tumors are negatively associated with gene cluster c (ANOVA p=1.2E-51),
representing genes involved in genetic disorders.
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Figure 6. Host irradiation interacts with Tgfb1 genotype to yield distinct gene profile that detects
ER-status of human breast cancers
SAM analysis of 24 Trp53 null tumors arising in Tgfb1 heterozygote hosts resulted in 199
genes regulated by at least 1.5-fold in tumors arising after host-irradiation. (A) The 199
genes segregate tumors of irradiated hosts (purple) apart from those in non-irradiated hosts
(red) in the heterozygote background, but did not do so for tumors from the wild type
background (B). (C) 337 human breast cancers from Prat et al. (2010) were clustered by the
human orthologs of the 199 genes present in that platform (luminal-A, dark blue; luminal-B,
light blue; HER2, purple; basal-like, red; claudin-low, black; normal-like, green;
unclassified, gray).
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